DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Zhang C, Wu Z, Li JW, Zhao H, Wang GQ.
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.
Int J Antimicrob Agents 2020;
55 (05) 105954
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.